Financials
- Market Capitalization 703.05 M
- Employee 942
- Founded 2007
- CEO N/A
- Website www.castlebiosciences.com
- Headquarter Delaware, United States
- FIGI BBG006YWVSR3
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2528 | OPK Opko Health, Inc. - Common Stock | 1.23 USD | +0.82% | -17.45% | -12.77% | -8.89% | 928.76 M USD | ||
| 2641 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 5.41 USD | -0.37% | -3.91% | +23.80% | +251.30% | 755.58 M USD | ||
| 2824 | FLGT Fulgent Genetics, Inc. - Common Stock | 20.49 USD | +0.15% | -1.06% | +12.58% | -13.29% | 581.93 M USD | ||
| 2841 | MYGN Myriad Genetics, Inc. - Common Stock | 6.13 USD | +1.49% | +7.17% | +42.23% | -25.88% | 578.97 M USD |
Frequently asked questions about Castle Biosciences, Inc. - Common stock
What is the Castle Biosciences, Inc. - Common stock stock price today?
The current price of Castle Biosciences, Inc. - Common stock (CSTL) is 23.18. Over the past 24 hours, the stock has changed by +0.26%. Follow the CSTL chart for real-time price dynamics.
What is the stock ticker of Castle Biosciences, Inc. - Common stock?
Castle Biosciences, Inc. - Common stock trades under the ticker CSTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Castle Biosciences, Inc. - Common stock stock going up?
CSTL has changed by -2.69% over the last week, +11.93% over the last month, and -5.83% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Castle Biosciences, Inc. - Common stock net income for the last quarter?
Castle Biosciences, Inc. - Common stock reported net income of -14.52 M for the last quarter. The previous quarter showed -2.33 M, which means net income changed by -522.73%.
How many employees does Castle Biosciences, Inc. - Common stock have?
As of the latest available data, Castle Biosciences, Inc. - Common stock has 942 employees. Workforce size can provide additional context about the company's scale and operations.
What is Castle Biosciences, Inc. - Common stock EBITDA?
Castle Biosciences, Inc. - Common stock EBITDA is -14.6 M, and its EBITDA margin is -17.48%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Castle Biosciences, Inc. - Common stock stock?
You can buy Castle Biosciences, Inc. - Common stock (CSTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Castle Biosciences, Inc. - Common stock stock?
Investing in Castle Biosciences, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CSTL chart and related analysis on metatrader.com as part of your research.